Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06NXK
|
||||
Former ID |
DNC010924
|
||||
Drug Name |
(R)-6-(2-(2-methylpyrrolidin-1-yl)ethyl)quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530904] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H20N2
|
||||
Canonical SMILES |
CC1CCCN1CCC2=CC3=C(C=C2)N=CC=C3
|
||||
InChI |
1S/C16H20N2/c1-13-4-3-10-18(13)11-8-14-6-7-16-15(12-14)5-2-9-17-16/h2,5-7,9,12-13H,3-4,8,10-11H2,1H3/t13-/m1/s1
|
||||
InChIKey |
HUQYUKHHFHNJRR-CYBMUJFWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [530904] | |
Histamine H3 receptor | Target Info | Inhibitor | [530904] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.